Qiyu Biotechnology (Shanghai)
Latest round
- Series C
Last raised
- Jun 2025
Total raised
- $45M
Investors
- 11
About Qiyu Biotechnology (Shanghai)
, trading as Qiyu Biotechnology (Shanghai), operates as a biopharmaceutical company which focuses on developing new drugs of cancer and autoimmune diseases, especially antibody. The company has cooperated with BRL Medicine, Bio Map, Hengrui Pharmaceuticals, and Precious Benchmark. The company has established several innovative platforms include phage display platform, hybridoma antibody humanization platform, single domain antibody platform and antibody engineering. Among them, the hybridoma antibody humanization platform is able to overcome immune tolerance and has completed several projects with antigens from multiple transmembrane regions, the phage display platform is a synthetic human library platform for bispecific antibody screening of common light chain libraries. The company's revenue is generated by providing drugs of cancer and autoimmune diseases.
Who invested in Qiyu Biotechnology (Shanghai)
11 investors across 4 rounds
See all investors in Qiyu Biotechnology (Shanghai)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qiyu Biotechnology (Shanghai)
Who invested in Qiyu Biotechnology (Shanghai)?
Qiyu Biotechnology (Shanghai) has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qiyu Biotechnology (Shanghai) raised?
Qiyu Biotechnology (Shanghai) has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Qiyu Biotechnology (Shanghai) last raise money?
Qiyu Biotechnology (Shanghai)'s most recent round on record is a Series C, in Jun 2025.
What does Qiyu Biotechnology (Shanghai) do?
, trading as Qiyu Biotechnology (Shanghai), operates as a biopharmaceutical company which focuses on developing new drugs of cancer and autoimmune diseases, especially antibody.
Where is Qiyu Biotechnology (Shanghai) headquartered?
Qiyu Biotechnology (Shanghai) is headquartered in Shanghai, China.
Which VCs invest in companies like Qiyu Biotechnology (Shanghai)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Qiyu Biotechnology (Shanghai)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Qiyu Biotechnology (Shanghai)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.